Type of information: IPO
Company: Armo BioScience
Funding type: IPO
- • On December 29, 2017, Armo BioSciences announced that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission relating to a proposed initial public offering of its common stock. The number of shares to be offered and the price range for the proposed offering have not yet been determined. Armo BioSciences has applied to list its common stock on the Nasdaq Global Select Market under the ticker symbol "ARMO." Jefferies LLC, Leerink Partners LLC and BMO Capital Markets Corp. are acting as joint book-running managers for the proposed offering. Robert W. Baird & Co. Incorporated is acting as co-manager.
Therapeutic area: Cancer - Oncology